Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial
Titel:
Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial
Auteur:
François, Bruno Lambden, Simon Fivez, Tom Gibot, Sebastien Derive, Marc Grouin, Jean-Marie Salcedo-Magguilli, Margarita Lemarié, Jérémie De Schryver, Nicolas Jalkanen, Ville Hicheur, Tarik Garaud, Jean-Jacques Cuvier, Valérie Ferrer, Ricard Bestle, Morten Pettilä, Ville Mira, Jean-Paul Bouisse, Camille Mercier, Emmanuelle Vermassen, Joris Huberlant, Vincent Vinatier, Isabelle Anguel, Nadia Levy, Mitchell Laterre, Pierre-François